Published in Healthcare Mergers, Acquisitions and Ventures Week, May 19th, 2007
Dr. Hawi will report to Jennifer L. Good, President and Chief Executive Officer of Penwest, and will work in close collaboration with Dr. Thomas Sciascia, who will be responsible for managing the clinical development and regulatory area of drug development in his capacity as Senior Vice President of Clinical Development, Regulatory Affairs and Chief Medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.